Company intelligence / Profile preview

Citrine Medicine

Ownership
Private
Development stage
Phase 3
01

Overview

Citrine Medicine is focused on importing and delivering rare disease medicines to the Chinese market[3]

Therapeutic areas
Rare Diseases
Industry
Non-Academic Healthcare
02

Drug pipeline

1 asset

pitolisant

Phase 3
Indications
Narcolepsy, Obstructive sleep apnea
03

Partnerships

Sinopharm Group[1]

Beyond the preview

Go deeper on Citrine Medicine.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Citrine Medicine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call